Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 164

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 164
---
ALE PROSPECTUS ALTERNATE PAGE]

USE OF PROCEEDS</div>

All shares of our Common Stock offered by this Resale Prospectus are being registered for the account of the Selling Stockholders identified herein. We will not receive any of the proceeds from the sale of these shares.

We will receive proceeds from any cash exercise of the Investor Warrants, which, if exercised in cash with respect to all of the 6,372,265 shares of common stock underlying the Investor Warrants, would result in gross proceeds to us of a maximum of approximately $7,413,436.

We intend to use any proceeds received by us from the cash exercise of the Investor Warrants for working capital purposes. As of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to us from the cash exercise of the Investor Warrants. Accordingly, our management will have broad discretion in the timing and application of these proceeds. The holders of the Investor Warrants may exercise the Investor Warrants at their own discretion and at any time until their expiration subject to and in accordance with the terms of the Investor Warrants. As a result, we cannot predict when or if the Investor Warrants will be exercised, and it is possible that the Investor Warrants may expire and never be exercised. In addition, the Investor Warrants are exercisable on a cashless basis if at the time of exercise there is no effective registration statement registering, or the prospectus contained therein is not available for, the issuance of shares of common stock for which the Investor Warrants are exercisable. As a result, we may never receive meaningful, or any, cash proceeds from the exercise of the Investor Warrants.

The Selling Stockholders identified herein may only sell their shares of our common stock pursuant to this prospectus at a fixed price of $$1.00 per share until such shares are quoted on the OTCQX or the OTCQB of OTC Markets, Inc. or until the shares of our common stock are listed on a national securities exchange. At and after such time, the selling stockholders may sell all or a portion of their shares through public or private transactions at prevailing market prices or at privately negotiated prices. We have included a fixed price at which Selling Stockholders may sell their shares pursuant to this prospectus prior to the time there is a public market for our stock in order to comply with the rules of the SEC that require that, if there is no market for the shares being registered, this registration